PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-477 Cr | ₹-434 Cr | ₹-1,339 Cr | ₹-1,812 Cr | ₹-4,480 Cr |
What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-477 Cr |
| Mar2024 | ₹-434 Cr |
| Mar2023 | ₹-1,339 Cr |
| Mar2022 | ₹-1,812 Cr |
| Mar2021 | ₹-4,480 Cr |
How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-477 Cr | Negative | |
| Mar2024 | ₹-434 Cr | Negative | |
| Mar2023 | ₹-1,339 Cr | Negative | |
| Mar2022 | ₹-1,812 Cr | Negative | |
| Mar2021 | ₹-4,480 Cr | - | |
Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,632.7 Cr | 1.8% | 5.3% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.8% |
5.3% |
-17.7% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses